121 related articles for article (PubMed ID: 21786574)
1. [Comparative characteristics of hemostasis system in patients with endstage renal disease admitted for urgent and elective hemodialysis].
Kotliarova GV; Kozlovskaia NL; Lashutin SV; Komiagin IuV; Shakhnova EA; Dobromyslov IA; Shilov EM; Nesterova SG
Ter Arkh; 2011; 83(6):36-41. PubMed ID: 21786574
[TBL] [Abstract][Full Text] [Related]
2. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
[TBL] [Abstract][Full Text] [Related]
3. [Ambulatory hemodialysis in the treatment of chronic uremia].
Dzhavad-Zade MD; Sultanov FM; Aliev SI
Klin Med (Mosk); 1978 Feb; 56(2):83-5. PubMed ID: 633832
[No Abstract] [Full Text] [Related]
4. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
5. [Changes in plasmic and platelet hemostasis in patients with chronic renal failure in hemodialysis].
Surovikina MS; Samoĭlenko VV; Vlasova EA; Vasilenko IA; Suslov VP
Urologiia; 2012; (1):25-9. PubMed ID: 22645997
[TBL] [Abstract][Full Text] [Related]
6. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
8. Impaired peripheral micro- and macrocirculation during hemodialysis in uremic patients.
Santesson P; Danielsson A; Iseda I; Adamson U; Lins PE; Jörneskog G
Int Angiol; 2010 Aug; 29(4):362-70. PubMed ID: 20671655
[TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
10. [Hyperprebetalipoproteinemia in patients treated by hemodialysis: clinico-experimental study].
Notarbartolo A; Stalteri A; Averna MR; Picone G; Piovana U; Montalto G; Battianati E; De Simone M
G Clin Med; 1980 May; 61(5):386-401. PubMed ID: 7450358
[No Abstract] [Full Text] [Related]
11. [Effects of extracorporeal hemodialysis on some aspects of hemostatic function in chronic uremia].
Cocconi G; Ferioli V; Franchini I
Minerva Nefrol; 1967; 14(4):162-8. PubMed ID: 5304654
[No Abstract] [Full Text] [Related]
12. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
13. [Renal insufficiency and hemostasis].
Nieth H
Thromb Diath Haemorrh; 1968; ():141-54. PubMed ID: 5726650
[No Abstract] [Full Text] [Related]
14. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment].
Malberti F; Ravani P
G Ital Nefrol; 2003; 20(2):127-32. PubMed ID: 12746797
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis.
Khanna D; Singal A; Kalra OP
Postgrad Med J; 2010 Nov; 86(1021):641-7. PubMed ID: 21037238
[TBL] [Abstract][Full Text] [Related]
16. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
[TBL] [Abstract][Full Text] [Related]
17. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
[TBL] [Abstract][Full Text] [Related]
18. Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis.
Fontán MP; Rodríguez-Carmona A; Cordido F; García-Buela J
Am J Kidney Dis; 1999 Nov; 34(5):824-31. PubMed ID: 10561137
[TBL] [Abstract][Full Text] [Related]
19. [Disorders of hemostasis and blood coagulation during uremia. 3. Role of platelet anomalies and action of hemodialysis and renal grafts].
Moriau M
Pathol Eur; 1966; 1(1):273-97. PubMed ID: 4865670
[No Abstract] [Full Text] [Related]
20. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.
Stack AG; Bloembergen WE
Am J Kidney Dis; 2001 Nov; 38(5):992-1000. PubMed ID: 11684552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
